11:11 AM EDT, 04/11/2024 (MT Newswires) -- European equities traded in the US as American depositary receipts were weaker Thursday morning, falling 0.91% to 1,353.49 on the S&P Europe Select ADR Index.

From continental Europe, the gainers were led by semiconductor company Sequans Communications (SQNS) and internet browser company Opera (OPRA), which rose 5.6% and 4.9% respectively. They were followed by biopharmaceutical companies DBV Technologies (DBVT) and Cellectis (CLLS), which increased 1.9% and 0.4% respectively.

The decliners from continental Europe were led by biopharmaceutical companies Calliditas Therapeutics (CALT) and Grifols (GRFS), which fell 6% and 5.2% respectively. They were followed by biotech firms Evaxion Biotech (EVAX) and Biophytis (BPTS), which dropped 4.5% and 3.7% respectively.

From the UK and Ireland, the gainers were led by biotech firm Autolus Therapeutics (AUTL) and biopharmaceutical company Akari Therapeutics (AKTX), which were up 3.1% and 1.5% respectively. They were followed by biopharmaceutical company TC Biopharm (TCBP) and pharmaceutical company AstraZeneca (AZN), which rose 1.4% each.

The decliners from the UK and Ireland were led by pharmaceutical company Avadel Pharmaceuticals (AVDL) and biotech firm Trinity Biotech (TRIB), which lost 4% and 3.1% respectively. They were followed by financial services companies Barclays (BCS) and HSBC (HSBC), which were off 2.8% and 2.7% respectively.

http://www.mtnewswires.com
Copyright © 2024 MT Newswires. All rights reserved. MT Newswires does not provide investment advice. Unauthorized reproduction is strictly prohibited.